The financial contribution of the multiple sclerosis specialist James N. Goldenberg, MD: I read Dr. Berger's 1 article with interest. The description of the money a physician spends on patient care as a contribution is concerning, particularly as we focus more than ever on excessive health care spending in the United States. The accounting definition of contribution is the amount of earnings remaining after all direct costs have been subtracted from revenue. 2 The brief acknowledgement at the end of the article that the true contribution margin cannot be calculated is too little, too late. In the era of value-based medicine, the value of a neurologist can only be calculated when the cost of care is compared to quality.
Josh Torgovnick, MD: I read the article by Dr. Berger 1 with interest. The United States already has the most expensive medical care in the world without a comparable improvement in outcome. The revised McDonald criteria are clear about the evaluation after 2 attacks: if dissemination in space and time and objective evidence of 1 lesion and good history for a second are present, no further testing is necessary. 5 With a spinal cord lesion, a pattern-shift visual evoked response might be useful, but I disagree with using a battery of evoked potential tests. Lumbar puncture should no longer be needed if history and MRI are typical. It is textbook 6 that oral steroids, 1,250 mg of prednisone, are equivalent to 1 g of Solu-Medrol, and patients can carry this on vacations or other travel and not need to be hampered by IVs. A baseline optical coherence tomography is reasonable but no one knows how often to repeat it. Many patients with MS do not progress 7 and identifying that group is more important than the financial benefits of which Dr. Berger speaks. Finally, the history and physical live on and tests are still extensions of these.
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Author Responds: Joseph R. Berger, MD: Both Dr. Goldenberg and Dr. Torgovnick are correct in asserting that the cost of medical care in the United States is astronomical and that the cost of care should correlate with outcomes and quality of care. However, that is not where the state of medicine is in the United States. Performing such a study for the MS population is no small undertaking and I would challenge anyone to provide a format to do so with the available data.
Health care systems are justifiably concerned about their bottom line. This analysis was performed in an effort to demonstrate that the MS specialist, often undervalued, contributes substantially to the financial well-being of the institution with which he or she is associated.
1 These data provide a framework for physicians providing MS care to negotiate with hospital administrators to provide adequate resources for their programs similar to that provided for cancer care and neurosurgery in light of their well-recognized financial contributions.
As a strong advocate of the value of a "hammer swinging" neurologic examination, 8 I agree fully with Dr. Torgovnick's assertion that not every test is required in assessing patients for MS. The studies performed were estimations of what is done in a large academic MS center where patients, often with unusual features, present for a second or third opinion regarding the accuracy of the diagnosis. Therefore, it is likely that the percentage of tests employed for the new patient is higher than in a community practice. 
Anton syndrome as a result of MS exacerbation
Nitin K. Sethi, MD: I read with interest the case report by Kim et al. 1 detailing Anton syndrome (AS) in a patient with multiple sclerosis. Apart from visual anosognosia, confabulation is an important symptom of AS. It is important to remember that AS on occasion may be associated with Charles Bonnet syndrome characterized by visual loss and hallucinations. Apart from imaging, cortical blindness with preserved pupillary reaction to light and accommodation, intact ocular movements, normal optic fundi, absent visual evoked potential, and absent optokinetic nystagmus may all aid in securing a clinical diagnosis of AS. Author Responds: Nina H. Kim, MD: We thank Dr. Sethi for his interest in our case report. 1 Cortical blindness can be ascertained by the examinations that Dr. Sethi highlights. It is also important that the patient is able to speak (and confabulate) to determine the diagnosis. AS is considered to be one of the disconnection syndromes that results in the fascinating phenomena of confabulation.
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